Marex Group plc Acquires New Position in Lam Research Corporation $LRCX

Marex Group plc bought a new position in Lam Research Corporation (NASDAQ:LRCXFree Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 11,046 shares of the semiconductor company’s stock, valued at approximately $1,075,000.

Several other large investors have also recently made changes to their positions in the business. Sava Infond d.o.o. increased its position in shares of Lam Research by 3.1% during the second quarter. Sava Infond d.o.o. now owns 75,250 shares of the semiconductor company’s stock valued at $7,325,000 after buying an additional 2,250 shares during the period. Horizon Bancorp Inc. IN purchased a new stake in Lam Research in the second quarter worth about $389,000. Empowered Funds LLC boosted its position in Lam Research by 10.5% during the 1st quarter. Empowered Funds LLC now owns 187,472 shares of the semiconductor company’s stock valued at $13,629,000 after acquiring an additional 17,833 shares in the last quarter. Genus Capital Management Inc. purchased a new position in shares of Lam Research during the 2nd quarter worth approximately $14,476,000. Finally, Glass Wealth Management Co LLC raised its position in shares of Lam Research by 8.5% in the 2nd quarter. Glass Wealth Management Co LLC now owns 28,870 shares of the semiconductor company’s stock worth $2,810,000 after acquiring an additional 2,270 shares in the last quarter. 84.61% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, insider Ava Harter sold 9,010 shares of the business’s stock in a transaction on Monday, October 27th. The stock was sold at an average price of $157.47, for a total value of $1,418,804.70. Following the completion of the transaction, the insider owned 56,786 shares in the company, valued at $8,942,091.42. The trade was a 13.69% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, SVP Vahid Vahedi sold 52,190 shares of the stock in a transaction on Monday, October 13th. The shares were sold at an average price of $138.90, for a total value of $7,249,191.00. Following the sale, the senior vice president directly owned 251,047 shares in the company, valued at $34,870,428.30. This trade represents a 17.21% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 102,608 shares of company stock worth $14,916,496 in the last 90 days. 0.31% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on the company. Zacks Research lowered Lam Research from a “strong-buy” rating to a “hold” rating in a research report on Monday, November 24th. B. Riley boosted their target price on shares of Lam Research from $160.00 to $175.00 and gave the company a “buy” rating in a report on Monday, October 20th. TD Cowen increased their price target on shares of Lam Research from $145.00 to $170.00 and gave the stock a “buy” rating in a research note on Thursday, October 23rd. Morgan Stanley lifted their price target on shares of Lam Research from $137.00 to $158.00 and gave the company an “equal weight” rating in a research report on Tuesday, December 2nd. Finally, Berenberg Bank upped their price objective on shares of Lam Research from $122.00 to $165.00 and gave the stock a “buy” rating in a report on Thursday, October 23rd. Twenty-six analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. According to data from MarketBeat.com, Lam Research presently has a consensus rating of “Moderate Buy” and a consensus price target of $152.87.

Read Our Latest Stock Report on Lam Research

Lam Research Stock Performance

Shares of LRCX stock opened at $160.52 on Monday. The company has a market capitalization of $201.62 billion, a price-to-earnings ratio of 35.36, a price-to-earnings-growth ratio of 1.65 and a beta of 1.77. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.60 and a current ratio of 2.21. Lam Research Corporation has a one year low of $56.32 and a one year high of $169.69. The company’s 50-day moving average is $152.53 and its 200 day moving average is $120.50.

Lam Research (NASDAQ:LRCXGet Free Report) last issued its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.22 by $0.04. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The business had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.23 billion. During the same period in the previous year, the company earned $0.86 earnings per share. The business’s revenue for the quarter was up 27.7% compared to the same quarter last year. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Sell-side analysts expect that Lam Research Corporation will post 3.71 EPS for the current fiscal year.

Lam Research Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 7th. Shareholders of record on Wednesday, December 3rd will be paid a dividend of $0.26 per share. This represents a $1.04 annualized dividend and a yield of 0.6%. The ex-dividend date is Wednesday, December 3rd. Lam Research’s dividend payout ratio (DPR) is currently 22.91%.

About Lam Research

(Free Report)

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

Featured Stories

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCXFree Report).

Institutional Ownership by Quarter for Lam Research (NASDAQ:LRCX)

Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.